Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.50 |
| ▸ | ESR2 known ✓ | Q92731 | 1/20 | 0.46 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 7/20 | 0.94 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.48 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.48 |
| ▸ | ITGAL | P20701 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4374970 | 1.00 | TSHR (0.94) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| SCHEMBL29732941 | 0.97 | — | — | |
| SCHEMBL158279 | 0.97 | — | — | |
| Nitrogen SCHEMBL4346621 | 0.92 | TSHR (0.90) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| SCHEMBL9082347 | 0.87 | TSHR (0.81) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| Hydrochloric Acid SCHEMBL29274500 | 0.87 | TSHR (0.71) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| SCHEMBL28200927 | 0.85 | CYP3A4 (0.77) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| Acetonitrile SCHEMBL9412155 | 0.84 | CYP3A4 (0.74) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| Formic Acid SCHEMBL27621713 | 0.84 | TSHR (0.74) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 | |
| Nitrogen SCHEMBL28997928 | 0.82 | TSHR (0.71) | TSHRCYP3A4ALDH1A1MAPK1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591505-A | 2-Chlorophenylhydrazine hydrochloride and preparation process thereof | 白银星宇生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-115850123-B | Preparation method of 2, 4-dichloroaniline/hydrazine | 山东潍坊润丰化工股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-115850123-A | Preparation method of 2, 4-dichloroaniline/hydrazine | 山东潍坊润丰化工股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-114989040-A | Synthetic method of mefenpyr-diethyl intermediate | 南京正荣医药化学有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-108821939-A | A kind of synthetic method of Ciprofloxacin intermediate 2,4 dichloro fluorobenzene | 江苏沙星化工有限公司 | 2018-11-16 | — | — | CN | claimed |
| CN-119591505-B | 2-Chlorophenylhydrazine hydrochloride and preparation process thereof | 白银星宇生物科技有限公司 | 2025-10-03 | — | — | CN | disclosed |
| CN-119591505-A | 2-Chlorophenylhydrazine hydrochloride and preparation process thereof | 白银星宇生物科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119591505-A | 2-Chlorophenylhydrazine hydrochloride and preparation process thereof | 白银星宇生物科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-118255672-A | Method and equipment for preparing 2,4, 6-trichloroaniline by continuous chlorination | 联化科技（德州）有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-115850123-B | Preparation method of 2, 4-dichloroaniline/hydrazine | 山东潍坊润丰化工股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-115850123-B | Preparation method of 2, 4-dichloroaniline/hydrazine | 山东潍坊润丰化工股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-115850123-A | Preparation method of 2, 4-dichloroaniline/hydrazine | 山东潍坊润丰化工股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-113929553-A | Synthetic method of 2, 4-dichlorofluorobenzene | 山东国邦药业有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-110590564-A | Method for synthesizing 2, 4-dichloroaniline by continuous chlorination process | 湖南比德生化科技股份有限公司 | 2019-12-20 | — | — | CN | disclosed |
| CN-108821939-A | A kind of synthetic method of Ciprofloxacin intermediate 2,4 dichloro fluorobenzene | 江苏沙星化工有限公司 | 2018-11-16 | — | — | CN | disclosed |
| CN-103102276-A | Method for preparing 3,5-dichloroaniline | JIANGSU ANPON ELECTROCHEMICAL CO LTD | 2013-05-15 | — | — | CN | disclosed |
| EP-0507317-B1 | Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives | OTSUKA PHARMA CO LTD (JP) | 1997-01-15 | — | — | EP | disclosed |
| US-5376686-A | Human, animal, medical equipment | OTSUKA PHARMACEUTICAL CO., LTD. | 1994-12-27 | — | — | US | disclosed |
| EP-0507317-A2 | Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-07 | — | — | EP | disclosed |
| US-4343810-A | Method of inhibiting sickling of sickle erythrocytes using 2-((haloanilino)methyl)-2-imidazolines | THE DOW CHEMICAL COMPANY (US) | 1982-08-10 | — | — | US | disclosed |